Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-07104091 |
| Trade Name | |
| Synonyms | PF 07104091|PF07104091 |
| Drug Descriptions |
PF-07104091 inhibits CDK2, which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation (NCI Drug Dictionary). |
| DrugClasses | CDK2 Inhibitor 31 |
| CAS Registry Number | 2460249-19-6 |
| NCIT ID | C175251 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fulvestrant + PF-07104091 + PF-07220060 | Fulvestrant PF-07104091 PF-07220060 | 0 | 1 |
| Letrozole + Palbociclib + PF-07104091 | Letrozole PF-07104091 Palbociclib | 0 | 1 |
| Letrozole + PF-07104091 + PF-07220060 | Letrozole PF-07104091 PF-07220060 | 0 | 1 |
| Palbociclib + PF-07104091 | PF-07104091 Palbociclib | 0 | 1 |
| PF-07104091 | PF-07104091 | 0 | 1 |
| PF-07104091 + PF-07220060 | PF-07104091 PF-07220060 | 0 | 1 |